CureVac’s Covid Vaccine Performed Badly in Trial, In Part Due to Variants The results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said. https://ift.tt/2XidLiy https://nyti.ms/3eyQv5F

The results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said.

from NYT > Top Stories https://nyti.ms/2Ub8Dh4
via IFTTT